Difference between revisions of "Team:Peking/Practices"

 
(20 intermediate revisions by 4 users not shown)
Line 7: Line 7:
 
   <meta name="Peking-iGEM-2015" content="iGEM - Peking iGEM 2015">
 
   <meta name="Peking-iGEM-2015" content="iGEM - Peking iGEM 2015">
 
   <!--add  ?action=raw&amp;ctype=text/css    when using Css-->
 
   <!--add  ?action=raw&amp;ctype=text/css    when using Css-->
−
   <link rel="stylesheet" href="https://2015.igem.org/Template:Peking/CSS?action=raw&amp;ctype=text/css" type="text/css" media="screen">
+
   <link rel="stylesheet" href="https://2015.igem.org/Template:Peking/new?action=raw&amp;ctype=text/css" type="text/css" media="screen">
−
   <link rel="stylesheet" type="text/css" href="https://2015.igem.org/Template:Peking/CSS/Style?action=raw&amp;ctype=text/css" media="screen">
+
   <link rel="stylesheet" type="text/css" href="https://2015.igem.org/Template:Peking/Style/new?action=raw&amp;ctype=text/css" media="screen">
−
   <link rel="stylesheet" type="text/css" href="https://2015.igem.org/Template:Peking/CSS/Responsive?action=raw&amp;ctype=text/css" media="screen">
+
   <link rel="stylesheet" type="text/css" href="https://2015.igem.org/Template:Peking/Responsive/new?action=raw&amp;ctype=text/css" media="screen">
−
   <link rel="stylesheet" type="text/css" href="https://2015.igem.org/Template:Peking/CSS/Animate?action=raw&amp;ctype=text/css" media="screen">
+
   <link rel="stylesheet" type="text/css" href="https://2015.igem.org/Template:Peking/Animate/new?action=raw&amp;ctype=text/css" media="screen">
−
   <link rel="stylesheet" type="text/css" href="https://2015.igem.org/Template:Peking/Blue?action=raw&amp;ctype=text/css " title="blue" media="screen" />
+
   <link rel="stylesheet" type="text/css" href="https://2015.igem.org/Template:Peking/Blue/new?action=raw&amp;ctype=text/css " title="blue" media="screen" />
 
   <style type="text/css">/*get rid of the annoying iGEM style*/
 
   <style type="text/css">/*get rid of the annoying iGEM style*/
 +
        #top_menu_inside, #top_menu_inside:before, #top_menu_inside:after { -webkit-box-sizing: content-box; -moz-box-sizing: border-box; box-sizing: content-box;}
 +
        #top_menu_under{font-size: 12px;}
 +
        #top_menu_14{font-size: 12px; height:18px}
 +
        #top_menu_inside li{font-size: 12px;}
 +
        #user_item{font-size: 12px;}
 
       #content{padding:0;border:0;width:100%;}
 
       #content{padding:0;border:0;width:100%;}
 
       .firstHeading{visibility:hidden;}
 
       .firstHeading{visibility:hidden;}
Line 28: Line 33:
 
     }
 
     }
 
     .back-to-top{z-index:9999;}
 
     .back-to-top{z-index:9999;}
−
ul.dropdown{margin-left: 0px; margin-top: 0px;}
+
ul.dropdown{margin-left: 0px; margin-top: 0px;}
 +
    .classic-title span {
 +
    position: absolute;
 +
    margin-top: -30px;
 +
    border-bottom-color: #00afd1;
 +
}
 +
.page-banner{
 +
  background-color:#e0e0e0;margin-top:1%;margin-bottom:20px;padding:20px;padding-top:40px;
 +
}
  
 
     </style>
 
     </style>
Line 55: Line 68:
 
                     <div class="navbar-collapse collapse"  style="padding-top:5px;padding-bottom:0">
 
                     <div class="navbar-collapse collapse"  style="padding-top:5px;padding-bottom:0">
 
                         <!-- Start Navigation List -->
 
                         <!-- Start Navigation List -->
−
                       <ul class="nav navbar-nav navbar-right " style="padding-bottom:15px;height:88px;padding-top:10px">
+
                       <ul class="nav navbar-nav navbar-right " style="padding-bottom:15px;padding-top:10px">
 
                             <li>
 
                             <li>
 
                                 <a href="https://2015.igem.org/Team:Peking/JudgingCriteria">Achievements</a>
 
                                 <a href="https://2015.igem.org/Team:Peking/JudgingCriteria">Achievements</a>
Line 72: Line 85:
 
                                     <li><a href="https://2015.igem.org/Team:Peking/Design">Overview</a>
 
                                     <li><a href="https://2015.igem.org/Team:Peking/Design">Overview</a>
 
                                     </li>
 
                                     </li>
−
                                     <li><a href="http://2015.igem.rg/Team:Peking/Design/Sequence-specific visualization">Sequence-specific Visualization</a>
+
                                     <li><a href="https://2015.igem.org/Team:Peking/Design/PC_Reporter">Paired<span style="text-transform:lowercase"> d</span>Cas9 Reporter</a>
−
                                    </li>
+
−
                                    <li><a href="https://2015.igem.org/Team:Peking/Design/Isothermal">Iso-thermal Amplification</a>
+
−
                                    </li>
+
−
                                    <li><a href="https://2015.igem.org/Team:Peking/Design/Array">Array-based diagnosis</a>
+
 
                                     </li>
 
                                     </li>
 +
                                  <li><a href="https://2015.igem.org/Team:Peking/Design/Isothermal">Iso-<span style="text-transform:lowercase">t</span>hermal Amplification</a>
 
                                     <li><a href="https://2015.igem.org/Team:Peking/Device">Hardware</a>
 
                                     <li><a href="https://2015.igem.org/Team:Peking/Device">Hardware</a>
 
                                     </li>
 
                                     </li>
Line 104: Line 114:
 
                                     <li><a href="https://2015.igem.org/Team:Peking/Practices/Engagement">Public Engagement</a>
 
                                     <li><a href="https://2015.igem.org/Team:Peking/Practices/Engagement">Public Engagement</a>
 
                                     </li>
 
                                     </li>
−
                                     <li><a href="https://2015.igem.org/Team:Peking/Practices/Outreach">Ethics and Economics Issue</a>
+
                                     <li><a href="https://2015.igem.org/Team:Peking/Practices/Outreach">Ethics and Economics Issues</a>
 
                                     </li>
 
                                     </li>
 
                                 </ul>
 
                                 </ul>
Line 134: Line 144:
 
      
 
      
 
     <!-- Start Page Banner -->
 
     <!-- Start Page Banner -->
−
     <div class="page-banner" style="background-color:#e0e0e0;margin-top:1%;margin-bottom:20px;padding:20px">  
+
     <div class="page-banner">  
 
       <div class="container">
 
       <div class="container">
 
         <div class="row">
 
         <div class="row">
 
           <div class="col-md-6">
 
           <div class="col-md-6">
−
             <h2 style="font-size:20px; margin-bottom:5px; padding-bottom:0"><b>Practices</b></h2>
+
             <h2 style="font-size:20px; margin-bottom:5px; padding-bottom:0">Practices</h2>
−
             <p style="margin-top:0px;font-size:14px">Study how our work affects the world, and how the world affects our work.</p>
+
             <p style="margin-top:0px;font-size:14px" id="goal">Study how our work affects the world, and how the world affects our work.</p>
 
           </div>
 
           </div>
 
           <div class="col-md-6">
 
           <div class="col-md-6">
Line 161: Line 171:
 
             <!-- Categories Widget -->
 
             <!-- Categories Widget -->
 
             <div id="sidebar1"class="widget widget-categories" >
 
             <div id="sidebar1"class="widget widget-categories" >
−
               <h4 style="font-size:18px">Overview<span class="head-line"></span></h4>
+
               <h4 style="font-size:18px" class="head-line">O<span style="text-transform:lowercase">verview</span></h4>
 
                 <ul>
 
                 <ul>
 
                 <li>
 
                 <li>
Line 173: Line 183:
 
             </div>
 
             </div>
 
             <div id="sidebar2"class="widget widget-categories">
 
             <div id="sidebar2"class="widget widget-categories">
−
               <h4 style="font-size:18px">Practices<span class="head-line"></span></h4>
+
               <h4 style="font-size:18px">O<span style="text-transform:lowercase">verview</span></h4>
 
               <ul>
 
               <ul>
 
                   <li>
 
                   <li>
Line 187: Line 197:
 
           <!--End sidebar-->
 
           <!--End sidebar-->
 
  <!-- Page Content -->
 
  <!-- Page Content -->
−
           <div class="col-md-9 page-content">
+
           <div class="col-md-9 page-content" style="text-align:justify;">
 
             <div id="practices">
 
             <div id="practices">
 
             <!-- Classic Heading -->
 
             <!-- Classic Heading -->
 
               <div id="Overview">
 
               <div id="Overview">
−
                 <h3 class="classic-title" id="goal" style="margin-top:50px"><span>Goal</span></h3>
+
                 <h3 class="classic-title" style="margin-top:50px"><span>Goal</span></h3>
 
                  
 
                  
 
                
 
                
  
 
               <div style="margin-top:30px; margin-bottom:0">
 
               <div style="margin-top:30px; margin-bottom:0">
−
               <p> This year Peking iGEM Team is trying to develop a brand new method for the detection of pathogenic microorganism. Particularly, we expect this method to be applied to the diagnosis of pulmonary tuberculosis as a proof of principle. To see whether our lab achievements can be really helpful to the clinical practice or not, in our human practice we paid the most attention to the clinical requirements for TB detection and the potential issues in economic and ethic perspectives. Additionally, education for both children and adults about the tuberculosis and synthetic biology was another important part. Overall, by the basic ideas of translational medicine, we have successfully set up a bridge between our technological advance and the clinical practices. </p>
+
               <p> This year Peking iGEM Team is trying to develop a brand new method for the detection of pathogenic microorganism. Particularly, we expect this method to be applied to the diagnosis of pulmonary tuberculosis as a proof of principle. To see whether our lab achievements can be really helpful to the clinical practice or not, in our human practice we paid the most attention to the clinical requirements for TB detection and the potential issues in economic and ethic perspectives. <span id="actions">Additionally</span>, education for both children and adults about the tuberculosis and synthetic biology was another important part. Overall, by the basic ideas of translational medicine, we have successfully set up a bridge between our technological advance and the clinical practices. </p>
  
  
−
               <h3 class="classic-title" id="actions" style="margin-top:50px"><span>Actions and Achievements</span></h3>
+
               <h3 class="classic-title" style="margin-top:50px"><span>Actions and Achievements</span></h3>
 
                 <div class="col-md-12">
 
                 <div class="col-md-12">
 
                 <div id="map" style="margin-top:20px;margin-bottom:20px;height:600px"></div>
 
                 <div id="map" style="margin-top:20px;margin-bottom:20px;height:600px"></div>
Line 209: Line 219:
 
           ['Peking Univeristy Health Science Center', 39.984391, 116.358611, 2],
 
           ['Peking Univeristy Health Science Center', 39.984391, 116.358611, 2],
 
           ['National Center for Tuberculosis Control and Prevention, China CDC', 40.182403, 116.304851, 3],
 
           ['National Center for Tuberculosis Control and Prevention, China CDC', 40.182403, 116.304851, 3],
 +
          ['Zhenghe County Hospital of Fujian Province', 27.369749, 118.863065, 4],
 +
          ['Zhenghe Research Institute for Tuberculosis', 27.368674, 118.868304, 5],
 
            
 
            
 
         ];
 
         ];
Line 279: Line 291:
 
                             <ul class="social-icons" style="padding-top:0:padding-bottom:0;margin-top:0;margin-bottom:0">
 
                             <ul class="social-icons" style="padding-top:0:padding-bottom:0;margin-top:0;margin-bottom:0">
 
                                 <li style="padding-top:0:padding-bottom:0;margin-top:0;margin-bottom:0"><!--HERE need to be changed-->
 
                                 <li style="padding-top:0:padding-bottom:0;margin-top:0;margin-bottom:0"><!--HERE need to be changed-->
−
                                     <a class="twitter" target="_blank" href="https://twitter.com/home/?status=https://2015.igem.org/Team:Peking/Practices">
+
                                     <a class="twitter" target="_blank" href="https://twitter.com/home/?status=https://2015.igem.org/Team:Peking">
 
                                       <i class="fa">
 
                                       <i class="fa">
 
                                         <img src="https://static.igem.org/mediawiki/2015/d/d0/Peking-twitter.png" style="height:20px;width:auto; margin-top:7px;">
 
                                         <img src="https://static.igem.org/mediawiki/2015/d/d0/Peking-twitter.png" style="height:20px;width:auto; margin-top:7px;">
Line 286: Line 298:
 
                                 </li>
 
                                 </li>
 
                                 <li style="padding-top:0:padding-bottom:0;margin-top:0;margin-bottom:0"><!--HERE need to be changed-->
 
                                 <li style="padding-top:0:padding-bottom:0;margin-top:0;margin-bottom:0"><!--HERE need to be changed-->
−
                                     <a class="facebook"target="_blank" href="https://www.facebook.com/sharer/sharer.php?u=https://2015.igem.org/Team:Peking/Practices">
+
                                     <a class="facebook"target="_blank" href="https://www.facebook.com/sharer/sharer.php?u=https://2015.igem.org/Team:Peking">
 
                                       <i class="fa">
 
                                       <i class="fa">
 
                                         <img src="https://static.igem.org/mediawiki/2015/0/0e/Peking-facebook.png" style="height:20px; margin-top:7px;">
 
                                         <img src="https://static.igem.org/mediawiki/2015/0/0e/Peking-facebook.png" style="height:20px; margin-top:7px;">
Line 293: Line 305:
 
                                 </li>
 
                                 </li>
 
                                 <li style="padding-top:0:padding-bottom:0;margin-top:0;margin-bottom:0"><!--HERE need to be changed-->
 
                                 <li style="padding-top:0:padding-bottom:0;margin-top:0;margin-bottom:0"><!--HERE need to be changed-->
−
                                     <a class="google"target="_blank" href="https://plus.google.com/share?url=https://2015.igem.org/Team:Peking/Practices">
+
                                     <a class="google"target="_blank" href="https://plus.google.com/share?url=https://2015.igem.org/Team:Peking">
 
                                       <i class="fa">
 
                                       <i class="fa">
 
                                         <img src="https://static.igem.org/mediawiki/2015/7/7a/Peking-google_plus.png" style="height:20px; margin-top:7px;">
 
                                         <img src="https://static.igem.org/mediawiki/2015/7/7a/Peking-google_plus.png" style="height:20px; margin-top:7px;">
Line 302: Line 314:
 
                             </ul>
 
                             </ul>
 
                         </div>
 
                         </div>
−
 
 
                         <div class="col-md-12 footer-widget social-widget row">
 
                         <div class="col-md-12 footer-widget social-widget row">
 
                             <h4>Follow Us<span class="head-line"></span></h4>
 
                             <h4>Follow Us<span class="head-line"></span></h4>

Latest revision as of 12:21, 17 November 2015

Peking iGEM 2015

Practices

Study how our work affects the world, and how the world affects our work.

Goal

This year Peking iGEM Team is trying to develop a brand new method for the detection of pathogenic microorganism. Particularly, we expect this method to be applied to the diagnosis of pulmonary tuberculosis as a proof of principle. To see whether our lab achievements can be really helpful to the clinical practice or not, in our human practice we paid the most attention to the clinical requirements for TB detection and the potential issues in economic and ethic perspectives. Additionally, education for both children and adults about the tuberculosis and synthetic biology was another important part. Overall, by the basic ideas of translational medicine, we have successfully set up a bridge between our technological advance and the clinical practices.

Actions and Achievements

Investigations on the current epidemic situation of TB
We first interviewed several representative clinicians from famous research institutes and primary hospitals, as well as the researchers of Beijing Research Institute for TB Control. Through the interviews, we understand the epidemic situation of TB nowadays (especially in China), the most widely used diagnostic techniques, and their clinical applications. We then visited the central laboratory of Beijing Research Institute for TB Control (BRITC) and discussed our proposal with the clinical researchers to obtain valuable suggestions.
Questionnaire survey
We learnt that the low awareness of TB is one of the main causes of high TB burden in China. On the other hand, a lack of public understanding of synthetic biology will be an obstacle for us to promote its application to clinical practices. Therefore, we investigated common people about their awareness of TB and synthetic biology.
Knowledge popularization of TB and synthetic biology
Questionnaire survey showed that most people don’t know much about either TB or synthetic biology, which reminds us of the urgency to disseminate the knowledge of them. Therefore, we set out to disseminate the knowledge to both adults and school students. Various approaches were taken, including handing out pamphlet, giving lectures, and hosting the student visit to iGEM lab.
Ethics discussion with the bioethicist
We first discussed with Doctor Xie Guangkuan, a researcher from the Institute of Medical Humanities of Peking University, about the ethical issues of synthetic biology, especially about our project. Then, a comprehensive assessment on the ethical problems of our project was performed after the discussion.
Economic assessment of our device
In our project a device for TB diagnosis was manufactured. Therefore, an economic assessment of the device was first performed. Then we interviewed clinical doctors, laboratory workers, and patients for investigating the market demand. This has guided our project toward a more practical direction.